# Fortitude Gold Corp: financial statements, quarterly

FTCO · OTC · CIK 1828377 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ftco.md) · [Financials](/companies/ftco/financials.md) · [Filings](/companies/ftco/filings.md) · [Insiders](/companies/ftco/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ftco/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [21.3](/filings/0001558370-24-014425.md) | [11.0 d](/filings/0001558370-25-001506.md) | [8.2](/filings/0001558370-25-005828.md) | [9.6](/filings/0001558370-25-010282.md) | [10.2](/filings/0001104659-25-106267.md) | [9.4 d](/filings/0001104659-26-022879.md) | [6.5](/filings/0001104659-26-058643.md) | [4.9](/filings/0001104659-26-090351.md) | [4.7](/filings/0001104659-25-106267.md) | [2.3 d](/filings/0001104659-26-022879.md) | [3.2](/filings/0001104659-26-058643.md) | [8.2](/filings/0001104659-26-090351.md) |
| Cost of revenue | $m | [0.0](/filings/0001558370-24-014425.md) | [0.1 d](/filings/0001558370-25-001506.md) | [0.0](/filings/0001558370-25-005828.md) | [0.1](/filings/0001558370-25-010282.md) | [0.0](/filings/0001104659-25-106267.md) | [0.0 d](/filings/0001104659-26-022879.md) | [0.1](/filings/0001104659-26-058643.md) | [0.0](/filings/0001104659-26-090351.md) | [0.1](/filings/0001104659-25-106267.md) | [0.0 d](/filings/0001104659-26-022879.md) | [0.0](/filings/0001104659-26-058643.md) | [0.0](/filings/0001104659-26-090351.md) |
| Gross profit | $m | [11.8](/filings/0001558370-24-014425.md) | [5.8 d](/filings/0001558370-25-001506.md) | [4.2](/filings/0001558370-25-005828.md) | [4.8](/filings/0001558370-25-010282.md) | [4.8](/filings/0001104659-25-106267.md) | [4.6 d](/filings/0001104659-26-022879.md) | [3.3](/filings/0001104659-26-058643.md) | [2.7](/filings/0001104659-26-090351.md) | [2.5](/filings/0001104659-25-106267.md) | [1.5 d](/filings/0001104659-26-022879.md) | [2.2](/filings/0001104659-26-058643.md) | [5.4](/filings/0001104659-26-090351.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [1.4](/filings/0001558370-24-014425.md) | [0.1 d](/filings/0001558370-25-001506.md) | [(0.1)](/filings/0001558370-25-005828.md) | [0.1](/filings/0001558370-25-010282.md) | [(0.1)](/filings/0001104659-25-106267.md) | [3.6 d](/filings/0001104659-26-022879.md) | [0.0](/filings/0001104659-26-058643.md) | [0.1](/filings/0001104659-26-090351.md) | [(0.1)](/filings/0001104659-25-106267.md) | [(0.0) d](/filings/0001104659-26-022879.md) | [0.0](/filings/0001104659-26-058643.md) | [0.0](/filings/0001104659-26-090351.md) |
| Net income | $m | [5.7](/filings/0001558370-24-014425.md) | [1.3 d](/filings/0001558370-25-001506.md) | [(0.0)](/filings/0001558370-25-005828.md) | [(0.1)](/filings/0001558370-25-010282.md) | [0.9](/filings/0001104659-25-106267.md) | [(2.8) d](/filings/0001104659-26-022879.md) | [1.2](/filings/0001104659-26-058643.md) | [0.8](/filings/0001104659-26-090351.md) | [0.2](/filings/0001104659-25-106267.md) | [(1.9) d](/filings/0001104659-26-022879.md) | [(1.6)](/filings/0001104659-26-058643.md) | [0.6](/filings/0001104659-26-090351.md) |
| Diluted EPS | $ per share | [0.24](/filings/0001558370-24-014425.md) | not reported | [0.00](/filings/0001558370-25-005828.md) | [(0.01)](/filings/0001558370-25-010282.md) | [0.04](/filings/0001104659-25-106267.md) | not reported | [0.05](/filings/0001104659-26-058643.md) | [0.03](/filings/0001104659-26-090351.md) | [0.01](/filings/0001104659-25-106267.md) | not reported | [(0.06)](/filings/0001104659-26-058643.md) | [0.02](/filings/0001104659-26-090351.md) |
| Basic EPS | $ per share | [0.24](/filings/0001558370-24-014425.md) | not reported | [0.00](/filings/0001558370-25-005828.md) | [(0.01)](/filings/0001558370-25-010282.md) | [0.04](/filings/0001104659-25-106267.md) | not reported | [0.05](/filings/0001104659-26-058643.md) | [0.04](/filings/0001104659-26-090351.md) | [0.01](/filings/0001104659-25-106267.md) | not reported | [(0.06)](/filings/0001104659-26-058643.md) | [0.02](/filings/0001104659-26-090351.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [52.0](/filings/0001558370-23-017118.md) | [48.7](/filings/0001558370-25-001506.md) | [41.9](/filings/0001558370-24-007043.md) | [32.9](/filings/0001558370-24-010374.md) | [30.3](/filings/0001558370-24-014425.md) | [27.1](/filings/0001104659-26-022879.md) | [21.4](/filings/0001558370-25-005828.md) | [17.1](/filings/0001558370-25-010282.md) | [11.7](/filings/0001104659-25-106267.md) | [4.7](/filings/0001104659-26-090351.md) | [10.0](/filings/0001104659-26-058643.md) | [13.5](/filings/0001104659-26-090351.md) |
| Current assets | $m | [105](/filings/0001558370-23-017118.md) | [75.3](/filings/0001558370-25-001506.md) | [69.1](/filings/0001558370-24-007043.md) | [52.1](/filings/0001558370-24-010374.md) | [45.4](/filings/0001558370-24-014425.md) | [41.9](/filings/0001104659-26-022879.md) | [34.2](/filings/0001558370-25-005828.md) | [28.6](/filings/0001558370-25-010282.md) | [36.3](/filings/0001104659-25-106267.md) | [38.6](/filings/0001104659-26-090351.md) | [41.3](/filings/0001104659-26-058643.md) | [46.0](/filings/0001104659-26-090351.md) |
| Total assets | $m | [136](/filings/0001558370-23-017118.md) | [135](/filings/0001558370-25-001506.md) | [130](/filings/0001558370-24-007043.md) | [126](/filings/0001558370-24-010374.md) | [127](/filings/0001558370-24-014425.md) | [122](/filings/0001104659-26-022879.md) | [120](/filings/0001558370-25-005828.md) | [117](/filings/0001558370-25-010282.md) | [136](/filings/0001104659-25-106267.md) | [136](/filings/0001104659-26-090351.md) | [146](/filings/0001104659-26-058643.md) | [152](/filings/0001104659-26-090351.md) |
| Current liabilities | $m | [7.4](/filings/0001558370-23-017118.md) | [8.0](/filings/0001558370-25-001506.md) | [5.8](/filings/0001558370-24-007043.md) | [3.7](/filings/0001558370-24-010374.md) | [3.9](/filings/0001558370-24-014425.md) | [4.1](/filings/0001104659-26-022879.md) | [3.5](/filings/0001558370-25-005828.md) | [2.0](/filings/0001558370-25-010282.md) | [7.9](/filings/0001104659-25-106267.md) | [9.1](/filings/0001104659-26-090351.md) | [10.0](/filings/0001104659-26-058643.md) | [10.6](/filings/0001104659-26-090351.md) |
| Total liabilities | $m | [13.6](/filings/0001558370-23-017118.md) | [14.5](/filings/0001558370-25-001506.md) | [12.5](/filings/0001558370-24-007043.md) | [10.5](/filings/0001558370-24-010374.md) | [13.7](/filings/0001558370-24-014425.md) | [14.0](/filings/0001104659-26-022879.md) | [13.6](/filings/0001558370-25-005828.md) | [9.8](/filings/0001558370-25-010282.md) | [29.4](/filings/0001104659-25-106267.md) | [31.8](/filings/0001104659-26-090351.md) | [31.4](/filings/0001104659-26-058643.md) | [29.6](/filings/0001104659-26-090351.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [122](/filings/0001558370-24-014425.md) | [121](/filings/0001104659-26-022879.md) | [118](/filings/0001558370-25-010282.md) | [115](/filings/0001104659-25-106267.md) | [113](/filings/0001104659-25-106267.md) | [108](/filings/0001104659-26-022879.md) | [107](/filings/0001558370-25-010282.md) | [107](/filings/0001104659-25-106267.md) | [107](/filings/0001104659-25-106267.md) | [104](/filings/0001104659-26-090351.md) | [114](/filings/0001104659-26-058643.md) | [119](/filings/0001104659-26-090351.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [9,827 d](/filings/0001558370-24-014425.md) | [361 d](/filings/0001558370-25-001506.md) | [(2,903)](/filings/0001558370-25-005828.md) | [(4,976) d](/filings/0001558370-25-010282.md) | [1,445 d](/filings/0001104659-25-106267.md) | [(204) d](/filings/0001104659-26-022879.md) | [(2,371)](/filings/0001104659-26-058643.md) | [(2,268) d](/filings/0001104659-26-090351.md) | [(3,839) d](/filings/0001104659-25-106267.md) | [(4,539) d](/filings/0001104659-26-022879.md) | [(3,391)](/filings/0001104659-26-058643.md) | [(4,358) d](/filings/0001104659-26-090351.md) |
| Capital expenditure | $k | [1,073 d](/filings/0001558370-24-014425.md) | [376 d](/filings/0001558370-25-001506.md) | [1,083](/filings/0001558370-25-005828.md) | [1,121 d](/filings/0001558370-25-010282.md) | [1,101 d](/filings/0001104659-25-106267.md) | [159 d](/filings/0001104659-26-022879.md) | [390](/filings/0001104659-26-058643.md) | [553 d](/filings/0001104659-26-090351.md) | [313 d](/filings/0001104659-25-106267.md) | [686 d](/filings/0001104659-26-022879.md) | [512](/filings/0001104659-26-058643.md) | [710 d](/filings/0001104659-26-090351.md) |
| Dividends paid | $k | [2,890 d](/filings/0001558370-24-014425.md) | [2,890 d](/filings/0001558370-25-001506.md) | [2,896](/filings/0001558370-25-005828.md) | [2,900 d](/filings/0001558370-25-010282.md) | [2,901 d](/filings/0001104659-25-106267.md) | [2,901 d](/filings/0001104659-26-022879.md) | [2,901](/filings/0001104659-26-058643.md) | [1,453 d](/filings/0001104659-26-090351.md) | [731 d](/filings/0001104659-25-106267.md) | [731 d](/filings/0001104659-26-022879.md) | [783](/filings/0001104659-26-058643.md) | [830 d](/filings/0001104659-26-090351.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [24.2](/filings/0001558370-23-017118.md) | [24.2](/filings/0001558370-24-007043.md) | [24.2](/filings/0001558370-24-010374.md) | [24.2](/filings/0001558370-24-014425.md) | [24.1](/filings/0001558370-25-005828.md) | [24.2](/filings/0001558370-25-010282.md) | [24.3](/filings/0001104659-25-106267.md) | [24.5](/filings/0001104659-26-058643.md) | [24.4](/filings/0001104659-26-090351.md) | [24.5](/filings/0001104659-25-106267.md) | [25.8](/filings/0001104659-26-058643.md) | [28.0](/filings/0001104659-26-090351.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 28,590,128 at 2026-08-03, from the cover of the [10-Q filed 2026-08-04](/filings/0001104659-26-090351.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.